STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ZYXI ZYNEX INCORPORATED StockScouter® Report

10

StockScouter® Score

ZYNEX INCORPORATED, a small cap growth company in the healthcare sector, is expected to outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is well above average. Positive
  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • One or more analysts has significantly increased quarterly earnings estimates for ZYXI. Positive

 

Concerns

  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.

Expected Risk/Return

Progress: 40% done.
Progress: 100% done.
Low
High

Core Model Grades

A
C
C
A

Previous Ratings

9
4
6